GB201819418D0 - Anti-viral compositions - Google Patents

Anti-viral compositions

Info

Publication number
GB201819418D0
GB201819418D0 GBGB1819418.3A GB201819418A GB201819418D0 GB 201819418 D0 GB201819418 D0 GB 201819418D0 GB 201819418 A GB201819418 A GB 201819418A GB 201819418 D0 GB201819418 D0 GB 201819418D0
Authority
GB
United Kingdom
Prior art keywords
viral compositions
viral
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1819418.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daniel Calladine Ltd
Original Assignee
Daniel Calladine Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daniel Calladine Ltd filed Critical Daniel Calladine Ltd
Priority to GBGB1819418.3A priority Critical patent/GB201819418D0/en
Publication of GB201819418D0 publication Critical patent/GB201819418D0/en
Priority to US17/296,299 priority patent/US12295956B2/en
Priority to AU2019389762A priority patent/AU2019389762B2/en
Priority to JP2021530309A priority patent/JP2022509240A/ja
Priority to ES19808612T priority patent/ES3035188T3/es
Priority to PCT/EP2019/082850 priority patent/WO2020109442A1/en
Priority to EP19808612.6A priority patent/EP3886861B1/en
Priority to CA3121051A priority patent/CA3121051A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GBGB1819418.3A 2018-11-29 2018-11-29 Anti-viral compositions Ceased GB201819418D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB1819418.3A GB201819418D0 (en) 2018-11-29 2018-11-29 Anti-viral compositions
US17/296,299 US12295956B2 (en) 2018-11-29 2019-11-28 Anti-viral compositions
AU2019389762A AU2019389762B2 (en) 2018-11-29 2019-11-28 Anti-viral compositions
JP2021530309A JP2022509240A (ja) 2018-11-29 2019-11-28 抗ウイルス組成物
ES19808612T ES3035188T3 (en) 2018-11-29 2019-11-28 Anti-viral compositions
PCT/EP2019/082850 WO2020109442A1 (en) 2018-11-29 2019-11-28 Anti-viral compositions
EP19808612.6A EP3886861B1 (en) 2018-11-29 2019-11-28 Anti-viral compositions
CA3121051A CA3121051A1 (en) 2018-11-29 2019-11-28 Anti-viral compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1819418.3A GB201819418D0 (en) 2018-11-29 2018-11-29 Anti-viral compositions

Publications (1)

Publication Number Publication Date
GB201819418D0 true GB201819418D0 (en) 2019-01-16

Family

ID=65024906

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1819418.3A Ceased GB201819418D0 (en) 2018-11-29 2018-11-29 Anti-viral compositions

Country Status (8)

Country Link
US (1) US12295956B2 (https=)
EP (1) EP3886861B1 (https=)
JP (1) JP2022509240A (https=)
AU (1) AU2019389762B2 (https=)
CA (1) CA3121051A1 (https=)
ES (1) ES3035188T3 (https=)
GB (1) GB201819418D0 (https=)
WO (1) WO2020109442A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240350570A1 (en) * 2023-04-19 2024-10-24 Daniel Tyler WHITING Topical skin care preparation comprising ephedra viridis

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
EP0662819A1 (en) 1992-09-09 1995-07-19 Gea Farmaceutisk Fabrik As PHARMACEUTICAL OIL EMULSION IN WATER WITH ANTIVIRAL ACTION CONTAINING 9- (2-HYDROXYETHOXY) METHYL] GUANINE (ACYCLOVIR) OR SALT OR ESTER OF SAID SUBSTANCE.
WO1997034607A1 (en) 1996-03-20 1997-09-25 Glaxo Group Limited Topical formulations of aciclovir
WO2000001390A1 (en) 1998-07-03 2000-01-13 Recordati S.A. Chemical And Pharmaceutical Company Topical aciclovir formulations
EP1044543A1 (fr) 1997-12-22 2000-10-18 Nortel Matra Cellular Modulation d'un signal numerique a spectre etroit et a enveloppe sensiblement constante
EP1741425A2 (en) 2004-04-05 2007-01-10 Laboratorios Liomont, S.A. de C.V. Novel antiviral pharmaceutical composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85083A1 (fr) * 1983-11-09 1985-07-17 Oreal Composition cosmetique ou pharmaceutique sous forme d'un baton ou stick constitue de deux phases grasses concentriques,son procede de preparation et etui en permettant sa conservation et sa distribution
RU2093140C1 (ru) 1995-03-09 1997-10-20 Товарищество с ограниченной ответственностью "Снежный Барс" Лечебно-профилактическая помада и способ ее приготовления
IT1287114B1 (it) * 1996-10-31 1998-08-04 Recordati Chem Pharm Composizioni farmaceutiche antierpetiche per applicatori topici, contenenti aciclovir
JP2003128521A (ja) * 2001-10-16 2003-05-08 Rohto Pharmaceut Co Ltd 外用製剤
RU2282473C2 (ru) * 2002-02-04 2006-08-27 Закрытое акционерное общество "Эвалар" Лечебно-профилактическая помада с противовирусной активностью и способ ее приготовления
US20080031979A1 (en) * 2006-08-04 2008-02-07 Claude Saliou Use of extracts for the treatment of viral disorders
US7695727B2 (en) * 2006-10-11 2010-04-13 Wyeth Llc Botanical butter stick lip balm
US8333955B2 (en) 2007-03-19 2012-12-18 Elc Management Llc High shine, stick-shaped cosmetic products
EP1977729B1 (en) * 2007-04-05 2010-03-03 Eckart GmbH Cosmetic compositions containing pearlescent pigments
CN100562631C (zh) 2007-04-05 2009-11-25 崔文瀛 球网壳组合结构
US20100135945A1 (en) * 2008-12-02 2010-06-03 Kreations By Kristin, Llc Gymnema-containing lip balm compositions and associated methods
WO2013077881A1 (en) 2011-11-23 2013-05-30 3B Pharmaceuticals, Inc. Antiviral formulations
US8722106B2 (en) * 2011-12-02 2014-05-13 The MotherVine Nutraceuticals Co. LLC Lip balm composition
BE1022817B1 (nl) * 2015-08-25 2016-09-13 Stasisport Pharma Nv Antivirale samenstelling en lippenstift omvattende genoemde samenstelling

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
EP0662819A1 (en) 1992-09-09 1995-07-19 Gea Farmaceutisk Fabrik As PHARMACEUTICAL OIL EMULSION IN WATER WITH ANTIVIRAL ACTION CONTAINING 9- (2-HYDROXYETHOXY) METHYL] GUANINE (ACYCLOVIR) OR SALT OR ESTER OF SAID SUBSTANCE.
WO1997034607A1 (en) 1996-03-20 1997-09-25 Glaxo Group Limited Topical formulations of aciclovir
EP1044543A1 (fr) 1997-12-22 2000-10-18 Nortel Matra Cellular Modulation d'un signal numerique a spectre etroit et a enveloppe sensiblement constante
WO2000001390A1 (en) 1998-07-03 2000-01-13 Recordati S.A. Chemical And Pharmaceutical Company Topical aciclovir formulations
EP1741425A2 (en) 2004-04-05 2007-01-10 Laboratorios Liomont, S.A. de C.V. Novel antiviral pharmaceutical composition

Also Published As

Publication number Publication date
CA3121051A1 (en) 2020-06-04
EP3886861A1 (en) 2021-10-06
EP3886861B1 (en) 2025-05-07
US12295956B2 (en) 2025-05-13
ES3035188T3 (en) 2025-08-29
US20220016124A1 (en) 2022-01-20
AU2019389762B2 (en) 2025-07-31
EP3886861C0 (en) 2025-05-07
WO2020109442A1 (en) 2020-06-04
AU2019389762A1 (en) 2021-07-01
JP2022509240A (ja) 2022-01-20

Similar Documents

Publication Publication Date Title
GB201811312D0 (en) Compositions
GB2586745B (en) Compositions
GB201916960D0 (en) Compositions
DK3924442T3 (en) Compositions
SG11202104306XA (en) Compositions
IL289125A (en) the vehicles
SG11202009259VA (en) Compositions
GB201810492D0 (en) Composition
GB201804434D0 (en) Composition
GB201908396D0 (en) Compositions
GB201811100D0 (en) Composition
GB201803923D0 (en) Compositions
GB201801596D0 (en) Composition
GB201919234D0 (en) Compositions
GB201805676D0 (en) Compositions
GB201810024D0 (en) Composition
SG11202105871QA (en) Anti-viral composition
GB201819418D0 (en) Anti-viral compositions
GB2570649B (en) Compositions
GB201819206D0 (en) Novel compositions
GB201809123D0 (en) Composition
ZA202005658B (en) Compositions
GB201820233D0 (en) Compositions
GB201816834D0 (en) Compositions
HK40058365A (en) Anti-viral composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)